Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Lokalnie zaawansowany rak szyjki macicy, który wymaga leczenia radioterapią.
- •Zgoda na udział w badaniu.
✗ Disqualifies
- •Osoby, które nie mogą wyrazić świadomej zgody.
- •Nowotwór naciekający dolne 2/3 pochwy.
- •Potrzeba zastosowania konkretnego rozmiaru implantów przy pierwszym zabiegu radioterapii.
- •Znana alergia na nylon.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 25, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Erasmus Medical Center
Rotterdam, Netherlands
Trial contact
H. Westerveld, MD, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.